VCEL (STOCKS)
Vericel Corporation
$34.440000
+0.740000 (+2.20%)
Prev close: $33.700000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Dominick C. Colangelo
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,753.57M
- Employees
- 357
- P/E (TTM)
- 106.41
- P/B (TTM)
- 4.81
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $276.26M |
| Benefits Costs and Expenses | $258.88M |
| Cost Of Revenue | $70.66M |
| Costs And Expenses | $258.88M |
| Gross Profit | $205.60M |
| Nonoperating Income/Loss | $6.33M |
| Operating Expenses | $194.56M |
| Selling, General, and Administrative Expenses | $166.99M |
| Research and Development | $27.56M |
| Operating Income/Loss | $11.04M |
| Income/Loss From Continuing Operations After Tax | $16.52M |
| Income/Loss From Continuing Operations Before Tax | $17.38M |
| Income Tax Expense/Benefit | $859.00K |
| Net Income/Loss | $16.52M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $16.52M |
| Net Income/Loss Available To Common Stockholders, Basic | $16.52M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $0.33 |
| Diluted Earnings Per Share | $0.32 |
| Basic Average Shares | 50,340,000 |
| Diluted Average Shares | 52,151,000 |
| Assets | $487.97M |
| Current Assets | $247.44M |
| Inventory | $17.56M |
| Other Current Assets | $229.88M |
| Noncurrent Assets | $240.53M |
| Liabilities | $133.33M |
| Current Liabilities | $49.15M |
| Accounts Payable | $15.83M |
| Wages | $3.01M |
| Other Current Liabilities | $30.31M |
| Noncurrent Liabilities | $84.18M |
| Equity | $354.64M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $354.64M |
| Liabilities And Equity | $487.97M |
| Net Cash Flow From Operating Activities | $51.91M |
| Net Cash Flow From Operating Activities, Continuing | $51.91M |
| Net Cash Flow From Investing Activities | -$43.94M |
| Net Cash Flow From Investing Activities, Continuing | -$43.94M |
| Net Cash Flow From Financing Activities | $7.07M |
| Net Cash Flow From Financing Activities, Continuing | $7.07M |
| Net Cash Flow | $15.04M |
| Net Cash Flow, Continuing | $15.04M |
| Comprehensive Income/Loss | $16.79M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $16.79M |
| Other Comprehensive Income/Loss | $16.79M |